SREBF1 and fatty liver disease: Previously, it was reported that a decrease in SIRT1 expression inhibits SREBP1 and lipogenesis [49], decreases PPARα levels which leads to the reduced use of fat as an energy source, and induces fat accumulation and hepatic steatosis [14, 49].